Company Information

CIN
Status
Date of Incorporation
08 October 2018
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2023
Last Annual Meeting
01 August 2023
Paid Up Capital
192,738
Authorised Capital
4,900,000

Directors

Shalini Rahul Purwar
Shalini Rahul Purwar
Director/Designated Partner
about 2 years ago
Rahul Purwar
Rahul Purwar
Director/Designated Partner
over 2 years ago
Ravindranath Kancherla
Ravindranath Kancherla
Director/Designated Partner
over 2 years ago
Shirish Arya
Shirish Arya
Director/Designated Partner
over 2 years ago
Chava Satyanarayana
Chava Satyanarayana
Director/Designated Partner
almost 4 years ago

Past Directors

Atharva Ajay Karulkar
Atharva Ajay Karulkar
Additional Director
about 4 years ago
Alka Dwivedi
Alka Dwivedi
Director
over 5 years ago

Patents

Inducible Cytokine Signals And Methods For Immunotherapy

ABSTRACT INDUCIBLE CYTOKINE SIGNALS AND METHODS FOR IMMUNOTHERAPY The present invention provides a novel Dimerization Induced Chimeric Cytokine Response Element (DICCRE) consisting of typically two receptor chains that may be the same or different. In each single subunit receptor, the subunits fulfil the dual ro...

Registered Trademarks

Immunoact Immunoadoptive Cell Therapy

[Class : 44] Provision Of Cell Therapy, Medical Treatment Including Cancer And Immune Disorders.

Immunoact Immunoadoptive Cell Therapy

[Class : 44] Provision Of Cell Therapy, Medical Treatment Including Cancer And Immune Disorders.